A Study for Participants Who Participated in Prior Clinical Studies of ASTX727 (Standard Dose)
- Status
- ENROLLING_BY_INVITATION
- Phase
- PHASE2
Clinical Trials Related to Acute Myeloid Leukemia
Related studies linked through entity extraction aliases.
Gemtuzumab Ozogamicin in Induction and Glasdegib in Postremission Therapy in Patients With AML (Acute Myeloid Leukemia)
- Status
- TERMINATED
- Phase
- PHASE3
Study of Enasidenib and Venetoclax in IDH2-Mutated Blood Cancers
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Study of DAC Combined With HAAG Regimen in Newly Diagnosed Younger AML Patients
- Status
- UNKNOWN
- Phase
- PHASE3
IMGN632 as Monotherapy or With Venetoclax and/or Azacitidine for Participants With CD123-Positive Acute Myeloid Leukemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Study of DAC Combined With HAAG Regimen in Newly Diagnosed AML Patients Older Than 60
- Status
- UNKNOWN
- Phase
- PHASE3
Cord Blood Transplant With Dilanubicel for the Treatment of HIV Positive Hematologic Cancers
- Status
- TERMINATED
- Phase
- PHASE2
LY3214996 in Patients With AML Who Are Not Candidates for Standard Therapy
- Status
- COMPLETED
- Phase
- PHASE1
A Phase 1b Master Trial to Investigate CPX-351 in Subjects With Previously Untreated Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE1
Italian Observational Study of Patients With Acute Myeloid Leukemia Treated With Small Molecule Inhibiting BCL-2
- Status
- UNKNOWN
- Phase
- N/A
Study of the Safety and Efficacy of Gemtuzumab Ozogamicin (GO) and Venetoclax in Patients With Relapsed or Refractory CD33+ Acute Myeloid Leukemia:Big Ten Cancer Research Consortium BTCRC-AML17-113
- Status
- COMPLETED
- Phase
- PHASE1
IA14 Induction in Young Acute Myeloid Leukemia
- Status
- UNKNOWN
- Phase
- PHASE2
Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
First in Human Study of Ziftomenib in Relapsed or Refractory Acute Myeloid Leukemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Randomized Clinical Study Assessing Haplo vs. URD in AML
- Status
- TERMINATED
- Phase
- NA
A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
AZA + Venetoclax as Maintenance Therapy in Patients With AML in Remission
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Screening Gene Mutations in Myeloid Cancers by Next Generation Sequencing to Improve Treatment Results
- Status
- UNKNOWN
- Phase
- N/A
Triplex Vaccine in Preventing CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplantation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Multi-Ctr PII Cmb.Modality Tx Ruxolitinib, Decitabine, and DLI for Post HSCT in AML/MDS
- Status
- COMPLETED
- Phase
- PHASE2